|
Download
Table of Contents
|
Bigpharma Agreements Handbook
2007
Report scope
Bigpharma Agreements Handbook 2007 is intended to provide the reader with an in-depth understanding of the partnering activities and interests of the leading fifty biopharma companies worldwide, enabling the effective assessment and selection of partners of choice, based on the latest knowledge of a company’s approach to partnering.
Bigpharma Agreements Handbook 2007 includes:
- The tools to enable effective and efficient preparation for partnering negotiation with bigpharma
- Detailed partnering activity and interests profiles for the leading fifty bigpharma companies
- Listing of over 1,000 contract documents between bigpharma and partner companies
- The leading M&A and partnering deals by value 2005-6
- Most active M&A and partnering dealmakers 2005-6
- The leading partnering resources
For each company in Bigpharma Agreements Handbook 2007, the available contracts are listed by deal type, including:
- Co-development
- Co-marketing
- Co-promotion
- Collaborative R&D
- Development
- Distribution
- Joint venture
- Licensing
- M&A
- Manufacturing
- Marketing
- Promotion
- Research
- Supply
Each deal title links via Weblink to an online version of the actual contract document, providing easy access to each contract document on demand. In addition, the contract document collection can be used offline and is available on CD-Rom.
The Bigpharma Agreements Handbook 2007 provides comprehensive access to available contract documents for each of the fifty bigpharma companies. Analyzing actual company agreements allows assessment of the following:
- What is actually granted by the agreement to the partner company?
- What exclusivity is granted?
- What is the payment structure for the deal?
- How are sales and payments audited?
- What is the deal term?
- How are the key terms of the agreement defined?
- How are IPRs handled and owned?
- Who is responsible for commercialization?
- Who is responsible for development, supply, and manufacture?
- How is confidentiality and publication managed?
- How are disputes to be resolved?
- Under what conditions can the deal be terminated?
- What happens when there is a change of ownership?
- What sublicensing and subscontracting provisions have been agreed?
- Which boilerplate clauses does the company insist upon?
- Which boilerplate clauses appear to differ from partner to partner or deal type to deal type?
- Which jurisdiction does the company insist upon for agreement law?
Table of Contents
Total pages: 310
|
